Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0019433; triglyceride catabolic process | 6.595E-09 | 3.590E-05 | FABP2, FABP3, FABP4, FABP5 |
BP | GO:0032501; multicellular organismal process | GO:0050968; detection of chemical stimulus involved in sensory perception of pain | 2.459E-06 | 1.983E-03 | TRPA1, TRPV1 |
BP | GO:0032501; multicellular organismal process | GO:0050955; thermoception | 2.459E-06 | 1.983E-03 | TRPA1, TRPV1 |
BP | GO:0050896; response to stimulus | GO:0043434; response to peptide hormone | 4.378E-06 | 3.178E-03 | FABP3, PPARA, TLR2, TRPV1, TSHR |
BP | GO:0009987; cellular process | GO:0038171; cannabinoid signaling pathway | 4.916E-06 | 3.453E-03 | CNR1, CNR2 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.228E-05 | 7.425E-03 | CYP1A2, CYP2C19 |
BP | GO:0008152; metabolic process | GO:0051001; negative regulation of nitric-oxide synthase activity | 1.718E-05 | 8.698E-03 | CNR1, CNR2 |
MF | GO:0005215; transporter activity | GO:0097603; temperature-gated ion channel activity | 2.459E-06 | 1.983E-03 | TRPA1, TRPV1 |
MF | GO:0060089; molecular transducer activity | GO:0004949; cannabinoid receptor activity | 2.459E-06 | 1.983E-03 | CNR1, CNR2 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.492E-03 | 2.246E-02 | CYP1A2 |
hsa00590 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.401E-03 | 1.401E-02 | ALOX15; CYP2C19 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.204E-06 | 5.510E-05 | CYP1A2; ALOX15; CYP2C19 |
hsa00982 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.732E-03 | 1.443E-02 | CYP1A2; CYP2C19 |
hsa03013 | RNA transport_Homo sapiens_hsa03013 | 1.028E-02 | 4.672E-02 | SMN2; SMN1 |
hsa03320 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.425E-11 | 1.213E-09 | FABP2; FABP3; FABP4; FABP5; PPARA; PPARD |
hsa04080 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 9.454E-05 | 1.576E-03 | CNR2; CNR1; TRPV1; TSHR |
hsa04726 | Serotonergic synapse_Homo sapiens_hsa04726 | 4.485E-03 | 2.246E-02 | ALOX15; CYP2C19 |
hsa04750 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 3.455E-03 | 2.159E-02 | TRPA1; TRPV1 |
hsa04923 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.145E-03 | 1.401E-02 | FABP4; TSHR |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Postherpetic neuralgia | B02.2, G44.847, G53.0 | CNR1; TRPV1 |
C00-D49: Neoplasms | Ovarian cancer | C56 | CNR1 |
C00-D49: Neoplasms | Overactive bladder disorder | C67, N32.81 | TRPV1; TRPV1 |
C00-D49: Neoplasms | Cancer | C00-C96 | TLR2 |
C00-D49: Neoplasms | Myelodysplastic syndrome | D46 | TLR2 |
C00-D49: Neoplasms | Prostate cancer | C61 | TLR2 |
C00-D49: Neoplasms | Thyroid cancer | C73 | TSHR |
C00-D49: Neoplasms | Thyroid cancer diagnosis | C73 | TSHR |
C00-D49: Neoplasms | Pancreatic cancer | C25 | TLR2 |
C00-D49: Neoplasms | Solid tumours | C00-D48 | TLR2 |